![Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells | ACS Synthetic Biology Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells | ACS Synthetic Biology](https://pubs.acs.org/cms/10.1021/acssynbio.1c00606/asset/images/large/sb1c00606_0005.jpeg)
Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells | ACS Synthetic Biology
![Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies: Trends in Cell Biology Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies: Trends in Cell Biology](https://www.cell.com/cms/attachment/40045831-7443-4851-ac99-229f25db36f2/gr1.jpg)
Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies: Trends in Cell Biology
![Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines](https://www.mdpi.com/cancers/cancers-14-00041/article_deploy/html/images/cancers-14-00041-g008.png)
Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines
![Frontiers | Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant? Frontiers | Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?](https://www.frontiersin.org/files/Articles/784024/fped-09-784024-HTML-r1/image_m/fped-09-784024-g001.jpg)
Frontiers | Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?
Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer | Journal of Medicinal Chemistry
![MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aan4470/asset/33b79a75-5694-4a27-931b-20f56bccb6fb/assets/graphic/aan4470-f1.jpeg)
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine
![BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27176-w/MediaObjects/41467_2021_27176_Fig1_HTML.png)
BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications
![Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/dede4b9f-f2af-4915-9cc7-a4c5d69f6391/fx1_lrg.jpg)
Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development
![Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/65e952ae-e757-4807-ad51-b3e27f846e35/adtp202100035-fig-0001-m.jpg)
Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library
![Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020 Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020](https://journals.sagepub.com/cms/10.1177/1078155219895079/asset/images/large/10.1177_1078155219895079-fig1.jpeg)
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020
![PDF) BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma PDF) BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma](https://i1.rgstatic.net/publication/356563513_BAF_complexes_drive_proliferation_and_block_myogenic_differentiation_in_fusion-positive_rhabdomyosarcoma/links/61a1c0777323543e210c1085/largepreview.png)